Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis
- 1 September 1997
- journal article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 84 (9) , 1239-1243
- https://doi.org/10.1002/bjs.1800840912
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Increased monocyte cytokine production in association with systemic complications in acute pancreatitisBritish Journal of Surgery, 1996
- Serum interleukin-6, interleukin-8, andβ 2-Microglobulin in early assessment of severity of acute pancreatitis comparison with serum C-reactive proteinDigestive Diseases and Sciences, 1995
- Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitisBritish Journal of Surgery, 1995
- Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonistBritish Journal of Surgery, 1994
- Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A.Gut, 1992
- Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.Gut, 1992
- lnterleukin‐8 and neutrophil activation in acute pancreatitisEuropean Journal of Clinical Investigation, 1992
- Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.Journal of Clinical Investigation, 1988
- Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitisBritish Journal of Surgery, 1987
- Controlled Clinical Trial of Peritoneal Lavage for the Treatment of Severe Acute PancreatitisNew England Journal of Medicine, 1985